I lead Digital Health for 澳门第一赌城在线娱乐 R&D. In 数字健康R&D, we are transforming R&D直通数字, data and AI to deliver new digital health solutions to improve outcomes and experience for patients, and to partner with colleagues globally to reimagine healthcare delivery.
I lead a diverse team focusing on accelerating and differentiating our clinical development programmes through digital health solutions and on the development of digital therapeutics. A recent example is the implementation and scale up of Unify, our new clinical study support platform which is now part of several of our trials around the world. Unify is enabling us to improve remote patient data collection, as well as supporting clinical trial accessibility, diversity and retention. We also work actively with the R&D therapy area teams to explore approaches that can combine our innovative new treatments with evidence-based digital health solutions, such as digital biomarkers, digital diagnostics and digital therapeutics.
A chemist by training, I have been part of the pharmaceutical industry for over 25 years. I have been at AstraZeneca for over 20 years in various roles across R&D和操作, including as Founder and Head of the Intelligent Pharmaceuticals group, Project Director in Chemistry, Manufacturing and Controls (CMC) and Project Lead roles across different therapy areas.
Throughout my time at AstraZeneca, I’ve been passionate about clinical innovation. I firmly believe we are moving towards a future where digital solutions have the potential to robustly improve medication use, collect data directly from patients to support self-management, and improve clinical outcomes.
Drug Information Association (DIA) Global Annual Meeting 2021
Clinical Trials Europe 2021
电流的作用
2015 – 2018
2013-2015
2011 – 2013
Veeva ID: Z4-35299
Date of preparation: July 2021